Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2026-02-26 @ 7:24 PM
Study NCT ID:
NCT02539368
Status:
COMPLETED
Last Update Posted:
2020-02-13
First Post:
2015-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions: